5 active trials 0 recruiting 1 disease areas
| Phase 4 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06834451 | Bioequivalence Study of Revolade® Eltrombopag 50 mg | Healthy | Active, Not Recruiting | 2025-06-19 |
| NCT06834503 | Bioequivalence Study of Clonazepam 2 Mg Tablets | Healthy | Not Yet Recruiting | 2025-03-10 |
| NCT06861842 | Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects | Healthy | Active, Not Recruiting | 2025-03-06 |
| NCT06823362 | Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed… | Healthy | Not Yet Recruiting | 2025-02-17 |
| NCT05944783 | Bioequivalence Studies of Dasatinib 100 Mg | Myeloma Multiple | Not Yet Recruiting | 2025-02-12 |
Multiple Myeloma (1)